Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement - a multi-centre case series from the United Kingdom.
Tucker, D. L.
Rule, S. A.
JournalBritish journal of haematology
RightsArchived with thanks to British journal of haematology
MetadataShow full item record
This article is currently freely available from the publisher's site (May 2016). Click on the 'Additional Link' above to access the full-text from the publisher's site.